GCK and Hypoglycemia: These studies support the work of Stanley et al. (153), who used intraperitoneal 2-deoxy-d-glucose (2-DG) injections to mimic hypoglycemia to assess neuronal activation in glucokinase-expressing cells stained with yellow fluorescent protein.